Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03695016 · ClinicalTrials.gov registry record · NA

Activity Prescription in Clinical Practice

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT03695016: Completed NA study, sponsored by University of Pittsburgh.

NCT03695016 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03695016, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

Most adults do not achieve the US aerobic physical activity (PA) guidelines (≥150 minutes/week of at least moderate intensity PA). Inadequate PA is considered a major risk factor for cardio-metabolic diseases and other poor health outcomes. Recommendations now endorse PA in reducing risk for certain diseases. Unfortunately, low PA levels are seldom identified and treated within clinical practice. This study will build on previous prevention efforts by focusing on the identifying and treating low PA levels in adults clinical care patients and referring them to an intervention that is feasible for delivery through clinical care.

Primary Outcome

Objectively measured change in moderate-vigorous activity between 0 and 3 months using ActiGraph accelerometer

Interventions

  • BEHAVIORAL ActiveGOALs

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2018-11-09
Est. Completion 2020-03-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03695016 record still lists

NCT03695016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which ActiveGOALs is the first listed.

NCT03695016 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03695016 about?

NCT03695016 is a clinical study titled "Activity Prescription in Clinical Practice". Most adults do not achieve the US aerobic physical activity (PA) guidelines (≥150 minutes/week of at least moderate intensity PA). Inadequate PA is considered a major risk factor for cardio-metabolic diseases and other poor health outcomes. Recommendations now endorse PA in reducing risk for certain...

What is the current status of trial NCT03695016?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2018-11-09. Estimated completion is 2020-03-30.

What interventions are being tested in trial NCT03695016?

The interventions under investigation include: ActiveGOALs (BEHAVIORAL).

Who is sponsoring clinical trial NCT03695016?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03695016's enrollment target sits among peer trials

79 1060th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03695016, the US trial registry maintained by the National Library of Medicine. NCT03695016 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.